Project cooperationUpdated on 17 February 2026
EU work packages to accelerate Phase I readiness
About
Ness Therapeutics is seeking EU partners to lead defined optimization work packages that accelerate Phase I readiness for N001, a self-administered intranasal, host-directed, virus-agnostic prophylactic medical countermeasure for URTI viruses.
Priority optimization work packages include:
-
Potency and functional assay optimization suitable for clinical-stage decision-making
-
Respiratory biomarker and translational readout strategy, including sampling and analysis plans
-
Phase I execution support, including protocol-ready operational planning and site readiness inputs
-
Regulatory support aligned with EU clinical expectations
We prefer partners who can commit to clear deliverables, tight timelines, and high-quality documentation. Details can be shared under CDA.
Stage
- Execution
Topic
- Biotech, Pharma and Cosmetics
Type
- Technical
Organisation
Similar opportunities
Partnership
EU GMP Clinical Manufacturing Partner for Phase I Supply
Ramtin Rahbar
Co-founder and Chief Technical Officer at Ness Therapeutics
Toronto, Canada
Expertise
CMC Leadership for Biologics: From Concept to Commercial Manufacturing
- Biotech, Pharma and Cosmetics
Ramtin Rahbar
Co-founder and Chief Technical Officer at Ness Therapeutics
Toronto, Canada
Expertise
Clinical Operations and Project Manager/Clinical Trial & Data Manager
- Healthcare
- Biotech, Pharma and Cosmetics
Madhuparna Ganguly
Clinical Operations & Project Manager | MBA candidate at Swiss Tropical and Public Health Institute
Zurich, Switzerland